live attenuated varicella vaccine
/ Sinopharm
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
June 18, 2023
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine
(clinicaltrials.gov)
- P3 | N=12440 | Active, not recruiting | Sponsor: China National Biotec Group Company Limited | Recruiting ➔ Active, not recruiting
Enrollment closed • Varicella Zoster
June 18, 2023
A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age
(clinicaltrials.gov)
- P3 | N=1200 | Active, not recruiting | Sponsor: China National Biotec Group Company Limited | Not yet recruiting ➔ Active, not recruiting
Enrollment closed • Varicella Zoster
May 03, 2023
A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age
(clinicaltrials.gov)
- P3 | N=1200 | Not yet recruiting | Sponsor: China National Biotec Group Company Limited
New P3 trial • Varicella Zoster
January 20, 2023
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine
(clinicaltrials.gov)
- P3 | N=12440 | Recruiting | Sponsor: China National Biotec Group Company Limited | Not yet recruiting ➔ Recruiting
Enrollment open • Varicella Zoster
January 03, 2023
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine
(clinicaltrials.gov)
- P3 | N=12440 | Not yet recruiting | Sponsor: China National Biotec Group Company Limited
New P3 trial • Varicella Zoster
1 to 5
Of
5
Go to page
1